loadpatents
name:-0.028321981430054
name:-0.014487981796265
name:-0.00041007995605469
Rothlein; Robert Patent Filings

Rothlein; Robert

Patent Applications and Registrations

Patent applications and USPTO patent grants for Rothlein; Robert.The latest application filed is for "rage fusion protein compositions and methods of use".

Company Profile
0.16.27
  • Rothlein; Robert - Summerfield NC
  • Rothlein; Robert - Greensboro NC
  • Rothlein; Robert - Danbury CT
  • Rothlein; Robert - Sumerfield NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Rage fusion proteins and methods of use
Grant 8,877,192 - Mjalli , et al. November 4, 2
2014-11-04
RAGE Fusion Protein Compositions And Methods Of Use
App 20130142792 - Rothlein; Robert ;   et al.
2013-06-06
Nucleic acid molecules encoding rage fusion proteins
Grant 8,344,120 - Mjalli , et al. January 1, 2
2013-01-01
Rage Fusion Proteins And Methods Of Use
App 20120171202 - MJALLI; ADNAN M.M. ;   et al.
2012-07-05
Rage Fusion Proteins, Formulations And Methods Of Use Thereof
App 20110282035 - Mjalli; Adnan M.M. ;   et al.
2011-11-17
Rage Fusion Proteins And Methods Of Use
App 20110244516 - Mjalli; Adnan M.M. ;   et al.
2011-10-06
Rage fusion proteins
Grant 7,981,423 - Mjalli , et al. July 19, 2
2011-07-19
RAGE fusion proteins, formulations, and methods of use thereof
Grant 7,981,424 - Mjalli , et al. July 19, 2
2011-07-19
Rage Fusion Proteins And Methods Of Use
App 20110124102 - Mjalli; Adnan M.M. ;   et al.
2011-05-26
Immunoglobulin Fusion Proteins and Methods of Making
App 20110110945 - Mjalli; Adnan M.M. ;   et al.
2011-05-12
Rage fusion proteins
Grant 7,901,688 - Mjalli , et al. March 8, 2
2011-03-08
Aryl and heteroaryl compounds, compositions, and methods of use
Grant 7,544,699 - Mjalli , et al. June 9, 2
2009-06-09
Rage Fusion Proteins and Methods of Use
App 20090060925 - Mjalli; Adnan M.M. ;   et al.
2009-03-05
Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith
App 20090035302 - Mjalli; Adnan M. M. ;   et al.
2009-02-05
Intercellular adhesion molecules and their binding ligands
App 20090035321 - Springer; Timothy A. ;   et al.
2009-02-05
Rage Fusion Proteins And Methods Of Use
App 20090004190 - Mjalli; Adnan M.M. ;   et al.
2009-01-01
Immunoglobulin fusion proteins and methods of making
App 20080199467 - Mjalli; Adnan M. M. ;   et al.
2008-08-21
Functional derivatives of ICAM-1 with altered ability to bind LFA-1 or HRV
Grant 7,354,588 - Springer , et al. April 8, 2
2008-04-08
Rage Fusion Proteins And Method Of Use
App 20080075733 - Mjalli; Adnan M.M. ;   et al.
2008-03-27
RAGE fusion proteins, formulations, and methods of use thereof
App 20080045455 - Mjalli; Adnan M.M. ;   et al.
2008-02-21
Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
App 20070219239 - Mjalli; Adnan M.M. ;   et al.
2007-09-20
Ligands for 17i as modulators of orthopox viruses and methods for discovery thereof
App 20070112523 - Mjalli; Adnan M. M. ;   et al.
2007-05-17
Aryl and heteroaryl compounds and methods to modulate coagulation
App 20060276518 - Mjalli; Adnan M. M. ;   et al.
2006-12-07
Aryl and heteroaryl compounds and methods to modulate coagulation
Grant 7,122,580 - Mjalli , et al. October 17, 2
2006-10-17
RAGE fusion proteins and methods of use
App 20060078562 - Mjalli; Adnan M.M. ;   et al.
2006-04-13
Rage fusion proteins and methods of use
App 20060030527 - Mjalli; Adnan M.M. ;   et al.
2006-02-09
Aryl and heteroaryl compounds, compositions, and methods of use
App 20050059705 - Mjalli, Adnan M.M. ;   et al.
2005-03-17
Rage antagonists as agents to reverse amyloidosis and diseases associated therewith
App 20050026811 - Mjalli, Adnan M. M. ;   et al.
2005-02-03
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
Grant 6,846,643 - Woska, Jr. , et al. January 25, 2
2005-01-25
Aryl and heteroaryl compounds and methods to modulate coagulation
App 20040110832 - Mjalli, Adnan M.M. ;   et al.
2004-06-10
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
App 20030175814 - Woska, Joseph R. JR. ;   et al.
2003-09-18
Combination anti-selectin and immunosuppressant therapy
App 20020164336 - Harrison, Paul C. ;   et al.
2002-11-07
Antisense modulation of cytohesin-1 expression
App 20020147164 - Bennett, C. Frank ;   et al.
2002-10-10
Antisense modulation of calreticulin expression
App 20020147165 - Bennett, C. Frank ;   et al.
2002-10-10
Antisense modulation of Talin expression
App 20020147166 - Bennett, C. Frank ;   et al.
2002-10-10
Methods and molecules useful for identifying molecules that bind LFA-1 and for determining receptor occupancy
App 20020068305 - Woska, Joseph R. JR. ;   et al.
2002-06-06
ICAM-1 derivatives with altered ability to bind LFA-1
Grant 6,358,510 - Springer , et al. March 19, 2
2002-03-19
Nucleotide sequence encoding intercellular adhesion molecule-1 and fragments thereof
Grant 5,612,216 - Springer , et al. March 18, 1
1997-03-18
R6-5-D6, an antibody which binds intercellular adhesion molecule-1
Grant 5,475,091 - Springer , et al. December 12, 1
1995-12-12
Method for detecting inflammation
Grant 5,472,849 - Rothlein , et al. December 5, 1
1995-12-05
Use of antibodies to intercellular adhesion molecule-1 (ICAM-1) in the treatment of asthma
Grant 5,324,510 - Wegner , et al. June 28, 1
1994-06-28
Intercellular adhesion molecules, and their binding ligands
Grant 5,284,931 - Springer , et al. February 8, 1
1994-02-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed